Preliminary Programme
|
14.00 |
WelcomeProf. Kurt Zatloukal – Project Coordinator – Director – Diagnostic and Research Institute of Pathology – Medical University of Graz – Austria Alexandru Padurean – Project Officer – HaDEA – EU Commission |
|
14.10 |
Addresses of MEPsVlad Voiculescu – Romania – RENEW Europe Dan Barna – Romania – RENEW Europe Aldo Patriciello – Italy – Patriots for Europe |
|
14.20 |
Session 1 – Medical need of NGS and precision diagnostics in cancer careModerator Prof. Ruth Ladenstein – Senior Consultant in Paediatric Oncology – St. Anna Children’s Cancer Research Institute – Austria, Coordinator ERN PaedCan – Board Member SIOP Europe Speaker Prof. Paolo Casali – Director Medical Oncology Unit 2 – & Secretary of the Ethics Committee – Istituto Nazionale – Milan – Italy – Project Coordinator of Joint Action On Networks of Expertise on Cancer – Board Member ESMO Panel Discussion Dr. Giovanni Apolone – President & Chairperson OECI EU Affairs – Scientific Director Foundation IRCCS – Istituto Nazionale dei Tumori – Milan – Italy Dr. Marc van den Bulcke PhD – Head of Service – Sciensano – Belgium Prof. Giuseppe Curigliano – Department of Oncology and Hemato-Oncology – University of Milano La Statale – Clinical Director – Division of Early Drug Development – European Institute of Oncology, IRCCS – Milan – Italy Prof. Francesco de Lorenzo – President F.A.V.O. – Italian Federation of Volunteer Cancer Patient Organisations Prof. Klaus Pantel – Director of Institute of Tumor Biology – University Hospital Eppendorf (UKE) – University of Hamburg – Germany Open Floor and Wrap Up |
|
15.20 |
Session 2: How can innovative technologies meet regulatory requirements for in vitro diagnostics and how European standards can helpModerator Prof. Kurt Zatloukal – Project Coordinator – Director – Diagnostic and Research Institute of Pathology – Medical University of Graz – Austria Speaker Innovative Workflow Technologies and European Standards meet Regulatory Requirements Dr. Uwe Oelmüller – Vice President, Head of the Molecular Diagnostics Technology Center for Sample Technologies – QIAGEN GmbH – Germany Panel Discussion Niklas Blomberg – Executive Director -IHI Innovative Health Initiative Francesca Fenizia – Executive Director IQNPath Flora Giorgio – Head of Unit Medical Devices D3 -DG Sante TBC Matthijs van Meerveld –EFPIA Oncology Platform Representative – Associate Vice President – Global Head of Access Policy & Patient Advocacy – Oncology Dept. – Menarini Jesus Rueda Rodriguez – Director-General of Strategies and Special Projects – MedTech Open Floor and Wrap Up |
|
16.20 |
Coffee Break |
| 16:40 |
Session 3: Health economic benefits of NGS as prerequisite for reimbursement schemes. How to overcome inequalities for patients in accessing precision diagnostics in EuropeModerator Prof. Wim van Harten – Group Leader Technologies & services in oncology – Survivorship & Rehabilitation Speaker Prof. Valesca Retèl – Endowed professor – Health Technology Assessment – Erasmus School of Health Policy & Management Panel Discussion Dr. Marc van den Bulcke PhD – Head of Service – Sciensano – Belgium Prof. Fortunato Ciardiello – Director – Division of Medical Oncology – Dean of the School of Medicine and Surgery – University of Campania Luigi Vanvitelli – Naples Francesco Florindi – Policy Officer – DG Research & Innovation – Unit D2 Health Innovations & Ecosystems – Brussels – Belgium Prof. Lotte Steuten – Deputy Chief Executive – Office of Health Economics Open Floor and Wrap Up |
ConclusionsProf. Marialuisa Lavitrano – School of Medicine and Surgery – University Milano-Bicocca – Italy |
|
| 18.00 – 19.00 |
Cocktail Reception |